Premium
Discovery of novel melanocortin 4 receptor selective MSH analogues
Author(s) -
Schiöth Helgi B,
Mutulis Felikss,
Muceniece Ruta,
Prusis Peteris,
Wikberg Jarl E S
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0701804
Subject(s) - receptor , melanocortin , melanocortin 1 receptor , chemistry , melanocortin receptor , melanocortin 4 receptor , stereochemistry , ligand (biochemistry) , melanocortin 3 receptor , biochemistry , gene , allele
We synthesized a novel series of cyclic melanocyte stimulating hormone (MSH) analogues and tested their binding properties on cells transiently expressing the human melanocortin 1 (MC 1 ), MC 3 , MC 4 and MC 5 receptors. We discovered that compounds with 26 membered rings of [Cys 4 , D ‐Nal 7 ,Cys 11 ]α‐MSH(4–11) displayed specific MC 4 receptor selectivity. The preference order of the different MC receptor subtypes for the novel [Cys 4 D ‐Nal 7 Cys 11 ]α‐MSH(4–11) analogues are distinct from all other known MSH analogues, particularly as they bind the MC 4 receptor with high and the MC 1 receptor with low relative affinities. HS964 and HS014 have 12 and 17 fold MC 4 /MC 3 receptor selectivity, respectively, which is much higher than for the previously described cyclic lactam and [Cys 4 ,Cys 10 ]α‐MSH analogues SHU9119 and HS9510. HS964 is the first substance showing higher affinity for the MC 5 receptor than the MC 1 receptor. HS014, which was the most potent and selective MC 4 receptor ligand ( K i 3.2 n M , which is ∼300 fold higher affinity than for α‐MSH), was also demonstrated to antagonize α‐MSH stimulation of cyclic AMP in MC 4 receptor transfected cells. We found that a compound with a 29 membered ring of [Cys 3 ,Nle 10 , D ‐Nal 7 ,Cys 11 ]α‐MSH(3–11) (HS010) had the highest affinity for the MC 3 receptor. This is the first study to describe ligands that are truly MC 4 selective and a ligand having a high affinity for the MC 3 receptor. The novel compounds may be of use in clarifying the physiological roles of the MC 3 , MC 4 and MC 5 receptors.